This project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No 955756.

Further ESRs join the InPharma network

Further Early Stage Researchers have joined the InPharma network over the summer. We would like the opportunity to welcome them to the project and shortly introduce them all to you.

Lotte Ejskjær (ESR4) has recently started at UCC and her research project focuses on molecular dynamics simulations to predict drug supersaturation (Dosup) in microemulsion formulations

Paul Vrenken (ESR10) is situated at Bayer and will research in silico methods for selecting oral formulations and dosing conditions in early clinical studies